Speakers

Hiroshi Abe, PhD

Professor, Department of Chemistry, Graduate School

Nagoya University

Shiro Akinaga, PhD

President and CEO

NANO MRNA, Co., Ltd.

Dr. Adrian Amador, PhD

Director of Process Chemistry

Cambrex

Dr. Tsubasa Aoki, PhD

Researcher

Ajinomoto Co.

Dr. Kerry Blanchard, MD, PhD

CEO, Chairman and Founder

Perpetual Medicines

Dr. Marvin Caruthers, PhD

Distinguished Professor, Biochemistry

University of Colorado

Mr. Carter Cooperman

Research Associate II

Ionis

David Craik, PhD

Professor of Biomolecular Structure

University of Queensland

Hagen Cramer, PhD

Chief Technology Officer

QurAlis

Mr. Keith Cronce

Chief Operating Officer

Fluid Air, A Division of Spraying Systems

Dr. Frederic Dargelas, PhD

Senior Director, Head of Business Development and Alliance Management

DelSiTech Ltd.

Ratmir Derda, PhD

Founder and CSO, 48 Hour Discovery

University of Alberta

Alaric Desmarchelier, PhD

Business Development Manager - Peptides

Almac Group

Dr. Tomaz Einfalt, PhD

Principal Investigator II xRNA

Novartis Institutes for BioMedical Research

Dr. Steven Fakharzadeh, MD, PhD

Global Medical Affairs Leader Immunodermatology

Janssen

Dr. Xinxin Gao, PhD

Principal Scientific Manager, Peptide Therapeutics

Genentech

Dr. Michael Gold, MD

Chief R&D Officer

Compass Pathways

Robert Gronke, PhD

Senior Principal Scientist, Technical Development

Biogen, Inc

Tamar Grossman, PhD

VP, Global Head of RNA, Gene Therapy and Delivery

Johnson & Johnson Innovative Medicine

Robert Hagopian

Director Business Development

PolyPeptide Group

Hanhua Huang, PhD

Vice President, Biology

Avidity Biosciences

Hiroshi Iwamura, PhD

Deputy Head of API Process Development Department

Chugai Pharmaceutical Co., Ltd.

Dr. Michiko Kimoto, PhD

Chief Operating Officer, R&D Director

Xenolis Pte. Ltd.

Dr. Thomas Langenickel, MD, PhD

Chief Medical Officer

Ethris GmbH

Frederic Legros, PhD

CEO

ARTHEx Biotech

John Lopez, PhD

Associate Director Science & Technology

Novartis

Zdravka Medarova, PhD

Co-Founder and Chief Scientific Officer

TransCode Therapeutics

Bruce Morimoto, PhD

Vice President, Drug Development

Alto Neuroscience

Markus Muttenthaler, PhD

Associate Professor, Neuropeptide Research

The University of Queensland and University of Vienna

Mehran Nikan, PhD

Research Fellow

Ionis Pharmaceuticals

Stefan Nilsson, Ph.D.

CEO

Lipigon Pharmaceuticals AB

Dr. Christian Adam Olsen, PhD

Professor, Drug Design and Pharmacology

University of Copenhagen

Chris Oswald

Founder, Owner, and Principal Consultant

Coswald Consulting LLC

Dinesh Parmar

Associate Director Regulatory Affairs

PolyPeptide Group

El Djouhar Rekaï, PhD

Head of Peptide Process Development & Manufacturing

PolyPeptide Group

Dr. Jonathan Rittichier, PhD

Chief Scientific Officer & Co-Founder

EnPlusOne BioSciences

Dr. Yvan Ruland, PhD

Technology Consultant Chromatography

Sartorius Stedim Singapore

Thomas Rupp

Managing Director

Axolabs Berlin GmbH

Yogesh Sanghvi, PhD

President

Rasayan Inc.

Hideaki Sato

President and CEO

Luxna Biotech

Tomomi Sato

Associate Director

Takeda Pharmaceutical Company Limited

Dr. Dong Shen, MD, PhD

CEO

RNAimmune, Inc.

Grzegorz Sienski, PhD

Director and Project Leader

AstraZeneca

Sirat Sikka

Senior Scientist, Applications and Innovation

Thermo Fisher Scientific

Lucas Siow

CEO and Co-Founder

ProteinQure

Hiroaki Suga, PhD

Professor of Chemistry, School of Science

University of Tokyo, Japan

Dr. Masayuki Sugimoto, PhD

Manager

Nitto Denko Corporation

Blake Unterreiner

Associate VP, Business Development & Customer Relations, NASD

Agilent Technologies

Sridhar Vaddeboina, Ph.D.

Vice President, Analytical Development

Wave Life Sciences

Dr. Mate Vadovics, PhD

Postdoctoral Fellow, Norbert Pardi Lab

University of Pennsylvania

Dr. Weimin Wang, PhD

Founder & CEO

Sanegene Bio

Pengyu Xu, PhD

President and Representative Director

SynCrest Inc.

Dr. Weiliang Xu, PhD

Associate Director of Business Development

PepLib